Pubblicazioni e abstracts

Pubblicazioni e abstract con Roberto Faggiani

Contatta il prof. Roberto Faggiani

Sanz Torre E, De Palo MG, Baldi F, Faggiani R, Leone D, Martinengo L, Pasquini G, Zampaletta C, Goletti M, Grasso P, Anti M:
Feasibility analysis of colorectal cancer screening in a high prevalence area; Digestive and Liver Disease vol. 33 A38 November 2001.

Anti M, De Palo MG, Pastorelli A, Sanz Torre E, Mutignani M, Faggiani R:
Sorveglianza e screening della poliposi adenomatosa familiare (FAP); Atti II Workshop sulle Malattie Apparato Digerente, Porto Ercole ottobre 2002 pag. 142.

Roselli P, Ghittoni G, Fusilli S, De Palo MG, Faggiani R, Pastorelli A, Sanz Torre E, Caturelli E, Anti M:
Contrast enhancement ultra sound (CEUS) and echo-colour doppler (CDUS) in the evaluation of Crohn’s disease activity index; Digestive and Liver Disease vol 37 OC3.3.7, March 2005 (I.F. Journal 1.818).

Sabates Belver J, De Palo MG, Pastorelli A, Faggiani R, Caturelli E, Gomes V, Jiricny I, Anti M, Marra G:
The transcriptional profile of colon adenomas differì drammatically from that of the normal colonic mucosal; Digestive and Liver Disease vol 37 PO1.92 March 2005 (I.F. Journal 1.818).

Faggiani R, Occhipinti P:
La Gastrostomia Endoscopica Percutanea (PEG) uso ed abuso; monografia AIGO “Highlights in Gastroenterologia”, Marzo 2006.

Sabates Belver J, De Palo MG, Menigatti M, Gomes V, Pastorelli A, Faggiani R, Caturelli E, Zampaletta C, Jiricny I, Marra G, Anti M:
Difference between transcriptional gene expression profile of colorectal adenomas and normal colorectal mucosa; Digestive and Liver Disease vol 38 S110  PA.156 April 2006 (I.F. Journal 1.818).

Sabates Belver J, De Palo MG, Menigatti M, Gomes V,Ranalli T,  Pastorelli A, Faggiani  R, Caturelli E, Zampaletta C, Jiricny I, Marra G, Anti M:
Colorectal adenomas and normal mucosa: differences between transcriptional gene expression profile; GUT  Endoscopy Supplement n° II Vol. 38 OP-G-295.

Amodio P.M., Faggiani R., Pastorelli A., Bigonzoni E., Consolo S., Piccioni E., Anti M., Macarone Palmieri R.:
Selected treatment for duodenal perforation after ERCP; Chir Ital 2007;59, 3:343-346.

Faggiani R.,  De Palo M.G.:
Infliximab e malattia di Crohn con interessamento colico; IMID Case Report Vol. III 2007.

Sabates- Bellver J, Van de Flier LG, De Palo MG, Cattaneo E, Maake C, Rehrauer H, Laczko E, Kurowski MA, Bujnicki JM, Menigatti M, Luz J, Ranalli TV, Gomes V, Pastorelli A, Faggiani R, Anti M, Jiricny J, Clevers H, Marra G:
Trascriptome Profile of Human Colorectal Adenomas; Mol Cancer Res 2007;5(12). December 2007.

Urgesi R, Zampaletta C, Masini A,  Pelecca G,  Pastorelli A, De Lorenzo A, Faggiani R.:
Spontaneous right ventricular thrombus in a patient with active ulcerative colitis and protein C deficieency: a review with a case report. Eur Rev Med Pharmacol Sci. 2010; 14.

Urgesi R, Pelecca G, Cianci R, Masini A, Zampaletta C, Riccioni ME, Faggiani R.:
Helicobacter pylori infection: Is sequential therapy superior to standard triple therapy? A single-centre Italian study in treatment-naive and non-treatment-naive patients. Can J Gastroenterol. 2011;25(6):315-8.

Urgesi R, Pastorelli A, Zampaletta C, Masini A, Pelecca G, Faggiani R, Anti M.
Obscure-occult bleeding: resolution of unexplained chronic sideropenic anaemia by colonoscopic removal of a colonic leiomyoma. BMJ Case Rep. 2011 Feb 2;2011.

Urgesi R, Pelecca G, Masini A, Pastorelli A, Zampaletta C, Lauria V, Faggiani R.:
Un caso di colite segmentaria associata a diverticoli e sospetta colite eosinofila trattato con mesalazina e beclometasone dipropionato. Acta Biomed 2011;82;Quaderno di Gastroenterologia III:17-20.

Palmieri, R. Macarone; Amodio, P.; Feroce, A.; Piciollo, M.; Faggiani, R.; Urgesi, R.; Zampaletta, C.
P.13.18 Effectiveness Of Fast-Track Rehabilitation In Colorectal Cancer Resection For Elderly Patients: An Italian Single Center Preliminary Experience.  Digestive and Liver Disease vol. 45 March, 2013. p. S187.

Palmieri, R. Macarone; Amodio, P.; Piciollo, M.; Feroce, A.; Urgesi, R.; Zampaletta, C.; Faggiani, R.
P.13.19 The Combined Role Of Temporary Diverting Ileostomy And The Fast-Track Protocol For The Treatment Of Rectal Extraperitoneal Carcinoma: An Italian Preliminary Single-Center Experience. Digestive and Liver Disease vol. 45 March, 2013. p. S187.

Polci R, Mangeri M, Faggiani R, Cristi E, Ranalli TV, Feriozzi S.:
Granulomatous interstitial nephritis in a patient with Crohn's disease. Ren Fail. 2012;34(9):1156-9. doi: 10.3109/0886022X.2012.711689. Epub 2012 Aug 8.

Petruzziello L, Hassan C, Alvaro D, Kohn A, Rossi Z, Zullo A, Cesaro P, Annibale B, Barca A, Di Giulio E, Giorgi Rossi P, Grasso E, Ridola L, Spada C, Costamagna G; Lazio Appropriateness Group.
Appropriateness of the indication for colonoscopy: is the endoscopist the 'gold standard'? [Collaborators (43)Di Matteo FM, Martino M, Faggiani R, Masini A, Bassi O, Ferrara M, Sgro A, Forti D, Anti M, Assisi D, Occhigrossi G, Caliendo S, Sbrozzi Vanni A, Delle Fave G, Tosoni M, Gigliozzi A, Tesi A, Marollo M, Giannelli C, Iacucci M, De Masi E, Apuzzo M, Tammaro G, Koch M, Dezi A, Tammaro L, Di Paolo MC, Vitale MA, Pallotta L, Ballanti R, Del Vecchio S, Pallone F, Stroppa I, Del Vecchio Bianco G, Brighi S, Cedola M, Pietropaolo V, Legnetti G, Attili A, Lamazza A, Pozzessere C, Viceconte G, Fracasso P. J Clin Gastroenterol. 2012 Aug;46(7):590-4.]

Tursi A., Elisei W., Picchio M., Forti G., Giorgetti G.M, Faggiani R., Zampaletta C., Brandimarte G.:
Diverticulosis in Inflammatory Bowel Diseases in Clinical Setting  Alimentary Pharmacology and Therapeutics.

Tursi A,Brandimarte G,DiMario F,Andreoli A,Annunziata ML,Astegiano M,Bianco MA,Buri L,Cammarota G,Capezzuto E,Chilovi F.Cianci M,Conigliaro MR,Del Favero G,Di Cesare L,Di Fonzo M,Elisei W,Faggiani R,Farroni F,Forti G,Bastianello G,Giorgetti GM,Giovannone M,Lecca PG,Loperfido S.,Marmo R,Morucci P,Occhigriossi G,Penna A,Rossi AF,Spadaccini A,Zampaletta C,Zilli M,Zullo A,Picchio M.:
Development and validation of an Endoscopic Classification of Diverticular Disease of the colon: the DICA Classification Digestive Disease 2015;33(1):68-76.

Tursi A., Elisei W., Picchio M., Faggiani R., Zampaletta C, Pelecca G, Brandimarte G.:
Comparison beetween infliximab and adalimumab for the treatment of perianal fistuling Crohn’s desease. Abstarct UEG-Week 2014-Vienna 18-22 ottobre.

Tursi A., Elisei W., Picchio M, Penna A, Lecca PG, Di Cesare L,  Forti G., Giorgetti G.M, Faggiani R., Zampaletta C, Pelecca G, Nenna R, Inchignolo CD, Brandimarte G.:
Effectiveness and safety of infliximab for ambulatory ulcerative colitis patients in primary gastroenterology centres. Abstract UEG-Week 2014-Vienna, 18-22 ottobre.

Tursi A., Elisei W., Picchio M, Penna A, Forti G., Giorgetti G.M, Faggiani R., Zampaletta C, Pelecca G, Brandimarte G.:
Effectiveness of adalimumab for ambulatory ulcerative colitis patients after failure of infliximab treatment. A first “real life” experience in primary gastroenterology centers in Italy. Ann Gastroenterol. 2014:27(4):369-373.

Tursi A., Elisei W., Picchio M, Penna A, Lecca PG,Forti G., Giorgetti G.M, Faggiani R., Zampaletta C, Pelecca G, Brandimarte G.:
Managing ambulatory ulcerative colitis patients with infliximab: a long term follow-up study in primary gastroenterology centers. Eur J Intern Med. 2014 Oct,25(8):757-61.

Tursi A., Elisei W., Picchio M., Faggiani R., Zampaletta C, Brandimarte G.
Letter: infliximab vs. Adalimumab in treating ambulatory perianal fistuling Crohn’s disease. Aliment Pharmacol Ther. 2014 Jul;40(2):218-20.

Tursi A., Elisei W., Picchio M., Zampaletta C, Pelecca G, Faggiani R., Brandimarte G.:
Comparison of the effectiveness of infliximab and adalimumab in preventing postoperative recurrence in patients with Crohn’s disease: an open label, pilot study. Tech Coloproctol. 2014 Nov;18(11):1041-6.

Tursi A., Elisei W., Picchio M, Forti G, Giorgetti G, Faggiani R., Zampaletta C, Brandimarte G. Letter:
Diverticulosis in inflammatory bowel disease. Aliment Pharmacol Ther. 2014 Apr;39(8):899-900.

Tursi A., Elisei W., Picchio M, Penna A, Lecca PG,Forti G., Giorgetti G.M, Faggiani R., Zampaletta C, Pelecca G, Brandimarte G.:
Effectiveness and safety of infliximab and adalimumab for ambulatory Crohn’s disease patients in primary gastroenterology centres.